ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1582

Cumulative Inflammatory Burden Is Independently Associated with Increased Arterial Stiffness in Patients with Psoriatic Arthritis

Jiayun Shen1, Qing Shang1, Ying Ying Leung2, Edmund Li1, Tracy Y. Zhu1 and Lai-Shan Tam1, 1Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, inflammation and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with psoriatic arthritis (PsA) are at increased risk of cardiovascular (CV) morbidity compared with the general population, probably as a result of chronic inflammation interacting with traditional CV risk factors. Two  cross-sectional studies (n<30) had reported increased arterial stiffness in patients with PsA. However, these studies were unable to assess the effect of inflammation over time. In this study, we examined whether the cumulative inflammatory burden over time is associated with an increase in arterial stiffness in a prospective cohort of PsA patients.

Methods: 72 PsA patients were followed up for 6.6±0.17 years. Clinical and cardiovascular risk factors were assessed at baseline and last visit. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured at each clinic visit. Cumulative inflammatory burden was represented by the cumulative averages of repeated measures of ESR and CRP, which were calculated from the area under the curve divided by the follow up time. Arterial stiffness was measured at the last visit as brachial-ankle pulse wave velocity (PWV) by a dedicated tonometry system (Non-Invasive Vascular Profile Device VP-2000; Omron Healthcare, Bannockburn, Illinois, USA). The correlation among PWV and cumulative averages of ESR (ca-ESR) and CRP (ca-CRP), as well as baseline and last follow up clinical parameters and CV risk factors were explored.

Results: The median PWV at last follow up was 1463 (interquartile range: 1331-1676) cm/s. There was a significant correlation between PWV and ca-ESR (Spearman’s rho: 0.390, p =0.001). PsA patients were divided into 2 groups based on whether their PWV value is ≥ (High PWV group) or <1463 cm/s (Low PWV group). The High PWV group had a significantly higher ca-ESR compared with the Low PWV group [29 (19-44) vs. 18 (10-32) mm/1st hr, p =0.005], There was also a trend suggestive of an increased ca-CRP in the High PWV group (p =0.087). The High PWV group were older, had a longer disease duration and a higher prevalence of having Framingham 10-year CV risk score (FRS) of > 10% at baseline. The High PWV group also had a lower body mass index (BMI), higher systolic blood pressure (SBP) and damage joint count at PWV assessment. In the regression analysis, high ca-ESR (defined as ≥75th percentile: 37 mm/1st hr) was associated with a higher likelihood of being in the High PWV group [OR: 5.969 (95% confidence interval: 1.361-26.176), p =0.018, adjusted for baseline clinical parameters and CV risk factors; and 5.140 (1.162-22.734), p=0.031, adjusted for last visit parameters, respectively].

Conclusion: Cumulative inflammatory burden was associated with increased arterial stiffness in patients with PsA even after adjustment for CV risk factors, emphasizing the important role of chronic inflammation in accelerating the development of CV risks in PsA patients.

Table 1. Clinical features at baseline and last follow up in patients with high and low PWV group

Baseline

Last follow up

Low PWV

High PWV

p value

Low PWV

High PWV

p value

Male gender

18 (50.0%)

18 (50.0%)

1.000

 

 

 

Age (years)

43.6±10.0

55.6±10.1

<0.001

 

 

 

PsA duration (years)

7.5±6.8

11.0±7.5

0.041

 

 

 

BMI (kg/m2)

25.7±4.0

24.6±3.3

0.184

25.7±3.6

23.9±3.1

0.028

Systolic BP

133±23

139±21

0.226

122±13

132±16

0.003

Framingham 10-year CVD risk > 10%

13 (39.4%)

23 (67.6%)

0.020

2 (5.6%)

8 (22.2%)

0.085

Damaged joint count

1 (0-3)

2 (0-6)

0.112

1 (0-4)

4 (1-8)

0.011


Disclosure:

J. Shen,
None;

Q. Shang,
None;

Y. Y. Leung,
None;

E. Li,
None;

T. Y. Zhu,
None;

L. S. Tam,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cumulative-inflammatory-burden-is-independently-associated-with-increased-arterial-stiffness-in-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology